GenoLogics Life Sciences Software Inc, an Illumina company Risk Report

🏗️ Operational & Business Continuity

GenoLogics Life Sciences Software Inc., now part of Illumina, appears to have maintained an operational focus post-acquisition, especially as a contributor to bioinformatics platforms and market reports. The company is involved in providing software solutions for the life sciences sector, supporting innovation and continuity in operations without apparent disruptions.

• Illumina acquired GenoLogics Life Sciences Software 🗓 August 4, 2015, indicating a strategic move for strengthening operational capabilities.
• The company's involvement in bioinformatics was highlighted in a report on the bioinformatics platforms market 🗓 July 8, 2025.
• Genologics was recognized among the top laboratory information management system providers 🗓 August 22, 2024, showcasing their operational excellence.

📜 Innovation & R&D

Through its integration with Illumina, GenoLogics Life Sciences Software is aligned with the forefront of laboratory information management systems and the wider bioinformatics sector. Continuous development and deployment of its software contribute to advancements in laboratory operations and bioinformatics research.

• Clarity LIMS software continues to be a significant offering, as noted by Illumina 🗓 April 1, 2024.
• The company was part of a discussion on the future growth of the bioinformatics market, showing its role in innovation 🗓 July 14, 2025.